| Factor | Score | Distribution | Value | Avg | Rank |
|---|---|---|---|---|---|
Valuation | 77 | 13.8x | 17.8x | Top tier | |
Growth | 55 | 6.5% | 7.1% | Around median | |
Quality | 76 | 17.2% | 4.5% | Top tier | |
Safety | 81 | 0.9x | 2.6x | Top tier | |
Capital Return | 63 | 0.29% | 2.12% | Around median | |
Momentum | 72 | 33.0% | 2.9% | Top tier | |
Sentiment | 22 | 2 | 3 | Bottom tier |
Estimates — analyst targets and a simplified DCF, not investment advice.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.
Interface, Inc. operates under the ticker TILE in the commercial flooring market and generates revenue from a portfolio that includes carpet tiles, LVT flooring, and nora rubber products. Its One Interface strategy relies on locally unified sales teams, global supply chain management, operational simplification, and investment in design and sustainability to increase sales and improve margins. In the first half of fiscal 2026, corporate offices represented approximately 44% of total billings, while healthcare and education were important growth drivers through the sale of multiple products to the same segments.
In Q2 fiscal 2026, revenue reached $395.7 million, up 5.4% on a reported basis and 3.8% on a currency-neutral basis, compared with $331.0 million in Q1 fiscal 2026. Gross profit was $178.1 million, equivalent to approximately 45.0% of revenue, while net income reached $51.4 million and earnings per share reached $0.88. Currency-neutral net sales grew 3.5% in the Americas and 4.5% in EAAA, while healthcare billings increased 19%, education 5%, and corporate offices 5%.
The 45.0% adjusted gross margin in Q2 fiscal 2026 included a nonrecurring benefit of $15.6 million from IEEPA tariff refunds, equivalent to 393 basis points and approximately $0.19 of diluted earnings per share. Pricing, mix, sales volume, and manufacturing efficiency collectively added 131 basis points, demonstrating that part of the improvement was operational and sustainable, but a substantial portion of the quarter's increase was exceptional. Adjusted operating income rose 34% to $74.9 million, adjusted net income to $51.5 million, and adjusted earnings before interest, taxes, depreciation, and amortization to $87.7 million.
Automated analysis for informational purposes only — not investment advice.
The analyst consensus is "Buy," with an average price target of $45, while the highest and lowest targets both match at $45, meaning there is no effective range reflecting differences in estimates. The $45 target is approximately 11% above the 52-week range high of $40.5, while the annual range extends from $24.4 to $40.5. This positive target should be weighed against the fact that the Q2 fiscal 2026 improvement benefited from a nonrecurring tariff refund and against a 54.6% price surge according to the news dated August 3, 2026, increasing valuation sensitivity to the sustainability of operating growth and underlying margins.
Figures in the text are as of 2026-09-01; the live price is shown at the top of the page.
Interface's revenue in Q2 fiscal 2026 reached approximately $395.7 million, up 5.4% on a reported basis and 3.8% on a currency-neutral basis. Gross profit reached $178.1 million, net income reached $51.4 million, and earnings per share reached $0.88. The results were supported by a 19% increase in healthcare billings, 5% in education, and 5% in corporate offices, along with currency-neutral sales growth in the Americas and EAAA. The margin also benefited from $15.6 million in IEEPA tariff refunds and 131 basis points related to pricing, mix, volume, and manufacturing efficiency.
Interface expects revenue of between $1.455 billion and $1.485 billion in fiscal 2026, a year consisting of 53 weeks, with the extra week occurring in Q1. It expects an adjusted gross margin of approximately 40.6%, adjusted selling, general, and administrative expenses of approximately $395 million, and capital expenditures of approximately $60 million. For Q3 fiscal 2026, revenue guidance ranges from $370 million to $380 million, with an adjusted gross margin of approximately 40.8%. The raised guidance is supported by 5% currency-neutral order growth and a 22% increase in backlog from the beginning of the fiscal year through the end of Q2.
The adjusted gross margin reached 45.0% in Q2 fiscal 2026, but it included 393 basis points from the nonrecurring $15.6 million IEEPA refund. Operating factors, including automation, pricing, mix, and higher volume, added another 131 basis points. Management expects a margin of approximately 39% in the second half of fiscal 2026, an increase of approximately 60 basis points year over year compared with the baseline. It also expects a margin of approximately 40.6% for fiscal 2026, including approximately 105 basis points related to the refund.
noravant Timber is rubber flooring that combines the characteristics of rubber with the appearance of wood grain and primarily targets patient rooms and the premium segment of the sheet vinyl market that Interface previously did not serve. The product won the Best Healthcare Product award at Clerkenwell Design Week, and samples began reaching sales teams in late Q1 fiscal 2026. Management said on the August 7, 2026, call that the product was not materially reflected in the 19% growth in healthcare billings during Q2. It indicated that specifications had been secured from major design firms and healthcare systems, while describing the platform as a long-term growth opportunity rather than a primary driver of results already reported.
Corporate offices represent approximately 44% of Interface's billings from the beginning of fiscal 2026, tying a significant portion of demand to office renovations and lease turnover. Between 15% and 20% of cost of goods sold is subject to tariffs, and the company also faces low-single-digit raw material inflation. Management did not assume additional tariff refunds after the $15.6 million benefit in Q2 fiscal 2026, so second-half margin guidance declines to approximately 39%. Adjusted selling, general, and administrative expenses also increased to $103.1 million from $93.4 million due to commissions, variable compensation, and currencies.
Interface generated $38.4 million in operating cash flow in Q2 fiscal 2026 and spent $12.2 million on capital expenditures in areas including automation and robotics. The company repurchased $8.8 million of shares during the quarter and approximately $21 million from the beginning of fiscal 2026, in addition to paying quarterly dividends. Q2 activity included the repurchase of approximately 310 thousand shares, compared with approximately 461 thousand shares in Q1 fiscal 2026. Management describes the repurchases as disciplined and opportunistic within a policy that balances investment in growth, leverage management, and returning cash to shareholders.
